| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-6386(97)90205-5 |
| P698 | PubMed publication ID | 9041220 |
| P2093 | author name string | D C Brennan | |
| M A Schnitzler | |||
| E L Spitznagel | |||
| W C Dunagan | |||
| R S Woodward | |||
| T C Bailey | |||
| P2860 | cites work | Cytomegalovirus as a risk factor in renal transplantation | Q72880726 |
| Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression | Q36825746 | ||
| The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation | Q40816360 | ||
| Ganciclovir | Q41095563 | ||
| Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus | Q41272721 | ||
| Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts | Q43927416 | ||
| Risk factors for survival following combined heart-lung transplantation. The first 100 patients. | Q44734075 | ||
| Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection | Q45840957 | ||
| Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens | Q48330648 | ||
| Donated organ as a source of cytomegalovirus in orthotopic liver transplantation | Q67506333 | ||
| The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients | Q69832476 | ||
| Cytomegalovirus matching in renal transplantation | Q69923138 | ||
| Acquisition of donor strains of cytomegalovirus by renal-transplant recipients | Q70138718 | ||
| CMV infection, class II antigen expression, and human kidney allograft rejection | Q70149430 | ||
| HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients | Q72238916 | ||
| P433 | issue | 3 | |
| P921 | main subject | serology | Q502159 |
| P304 | page(s) | 428-434 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation | |
| P478 | volume | 29 |
| Q74019516 | CMV infection as a contributory factor for renal allograft injury and loss |
| Q42235317 | Cytomegalovirus glomerulopathy and cytomegalovirus interstitial nephritis on sequential transplant kidney biopsies. |
| Q42250541 | Cytomegalovirus infection in renal transplant recipients: one center's experience |
| Q74681888 | Cytomegalovirus-induced glomerular vasculopathy in renal allografts: a report of two cases |
| Q43783687 | Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients |
| Q84859127 | Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation |
| Q33747809 | Human Cytomegalovirus Induces TGF-β1 Activation in Renal Tubular Epithelial Cells after Epithelial-to-Mesenchymal Transition |
| Q35919439 | Incidence of CMV-HCV coinfection in renal transplant recipient |
| Q34294779 | Infection in solid organ transplantation. |
| Q40531014 | Infections under immunosuppressive therapy following organ transplantation |
| Q41892541 | Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study |
| Q83828789 | Spectrum of cytomegalovirus-induced renal pathology in renal allograft recipients |
| Q44402541 | The Association of Cytomegalovirus Sero-Pairing with Outcomes and Costs Following Cadaveric Renal Transplantation Prior to the Introduction of Oral Ganciclovir CMV Prophylaxis |
| Q43466246 | Universal prophylaxis with gancyclovir preparation is not necessary in our kidney allograft recipients |
| Q37097708 | Viral infection after renal transplantation: surveillance and management |
| Q34198401 | Viral infections after renal transplantation |
| Q82770876 | [Intensive therapy after solid organ transplantation] |
Search more.